Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes: A Systematic Review and Network Meta-analysis.
Apostolos Tsapas, Ioannis Avgerinos, Thomas Karagiannis...
https://pubmed.ncbi.nlm.nih.gov/32598218/Actively Recruiting
Led by Umeå University · Updated on 2026-04-30
106
Participants Needed
3
Research Sites
N/A
Total Duration
Researchers are evaluating overweight adults with type 2 diabetes to study the effects of a total diet replacement aiming for weight loss and diabetes remission. The trial compares two follow-up methods eHealth-based remote support and traditional face-to-face visits. A healthy control group with normal glucose tolerance is also examined once for comparison but does not receive any intervention. The study aims to assess changes in blood sugar control and weight over time. Participants replace their usual diet with a low-calorie total diet replacement 850 kcalday for three months targeting a 15 kg weight loss and diabetes remission. After this period, food is gradually reintroduced with individualized calorie plans to prevent weight regain. Those not reaching weight loss goals may continue the diet replacement for up to two more months. Weight maintenance support includes a cognitive behavioral therapy program delivered either via an eHealth app with video calls or in-person visits, depending on group assignment. The study lasts for two years. Throughout the study, participants regularly record body weight, blood glucose, and blood pressure. HbA1c levels are measured multiple times, either at home or during visits. Various health and lifestyle factors are monitored, including medication use, blood lipids, liver enzymes, quality of life, and physical activity. After study completion, long-term outcomes will be tracked through national diabetes registries for up to 20 years. The healthy control group is examined once after one year for comparison.
CONDITIONS
The eHealth Diabetes Remission Trial
J
Julia Otten, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Umeå University
Lead Sponsor
Region Västerbotten
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 3 months, with up to 2 additional months if needed
Participants replace usual foods with a total diet replacement of 850 kcal/day aiming for weight loss and diabetes remission. This period lasts for 3 months, with an option to extend for 2 additional months if the weight loss goal is not met.
Scheduled video or face-to-face appointments depending on group assignment
Duration - Up to 21 months
Participants gradually reintroduce food with a tailored energy prescription to maintain weight loss, supported by a cognitive behavioural therapy program delivered via eHealth or face-to-face follow-up.
Regular video or face-to-face appointments for monitoring and support
Duration - Up to 20 years
After completing the 2-year study, participants will be followed through national diabetes registry data to monitor long-term diabetes remission and health outcomes.
Annual remote assessments based on registry data
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Apostolos Tsapas, Ioannis Avgerinos, Thomas Karagiannis...
https://pubmed.ncbi.nlm.nih.gov/32598218/Lucas Gladzki, Mattias Brunström, Julia Otten
https://pubmed.ncbi.nlm.nih.gov/42154590/Julia Otten, Anna Tellström, Claudia Schien...
https://pubmed.ncbi.nlm.nih.gov/40701606/Umeå University
Lead Sponsor
Region Västerbotten
Collaborating Sponsor